MRI of the prostate: Clinical relevance and emerging applications
暂无分享,去创建一个
Yousef Mazaheri | Amita Shukla-Dave | Hedvig Hricak | H. Hricak | Y. Mazaheri | A. Shukla-Dave | Ada Muellner | A. Muellner
[1] Peter Wust,et al. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. , 2007, European urology.
[2] Kemal Tuncali,et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image‐guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy , 2003, Cancer.
[3] G. Parker,et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. , 2004, Radiology.
[4] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[5] H. Hricak,et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.
[6] D. Rosenthal. Radiologic diagnosis of bone metastases , 1997, Cancer.
[7] Alexandra L Hanlon,et al. Prostate cancer radiotherapy dose response: an update of the fox chase experience. , 2004, The Journal of urology.
[8] J Kurhanewicz,et al. Dynamic contrast‐enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI , 2005, Magnetic resonance in medicine.
[9] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[10] A. D'Amico,et al. Transperineal magnetic resonance image guided prostate biopsy. , 2000, The Journal of urology.
[11] B. Misselwitz. MR contrast agents in lymph node imaging. , 2006, European journal of radiology.
[12] J. Moul,et al. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. , 1998, The Journal of urology.
[13] Steven J Haker,et al. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. , 2005, Urology.
[14] P. Therasse,et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Tristan Barrett,et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.
[16] E Bellon,et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. , 1999, International journal of radiation oncology, biology, physics.
[17] D P Dearnaley,et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.
[18] M V Knopp,et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.
[19] D P Dearnaley,et al. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. , 1999, The British journal of radiology.
[20] Emmanuel Itti,et al. Lymph node imaging: basic principles. , 2006, European journal of radiology.
[21] H. Hricak,et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. , 2007, International journal of radiation oncology, biology, physics.
[22] H. Hricak,et al. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. , 2005, The British journal of radiology.
[23] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[24] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[25] M. Kattan,et al. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy , 2009, BJU international.
[26] C C Ling,et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.
[27] P. Walsh. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. , 2005, The Journal of urology.
[28] Masoom A Haider,et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[29] M. Cooperberg,et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. , 2004, The Journal of urology.
[30] M. Kattan,et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. , 1998, Journal of the National Cancer Institute.
[31] T. Scheenen,et al. Prostate cancer: local staging at 3-T endorectal MR imaging--early experience. , 2006, Radiology.
[32] Jason A Koutcher,et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.
[33] Jing Chen,et al. Monitoring prostate thermal therapy with diffusion‐weighted MRI , 2008, Magnetic resonance in medicine.
[34] Michael W Kattan,et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. , 2004, Radiology.
[35] P. Scardino,et al. The clinical features of anterior prostate cancers , 2006, BJU international.
[36] Katarzyna J Macura,et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. , 2008, European urology.
[37] Nobuhiko Hata,et al. Magnetic Resonance-guided Prostate Interventions , 2005, Topics in magnetic resonance imaging : TMRI.
[38] D P Dearnaley,et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.
[39] Alexandra L Hanlon,et al. Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. , 2002, Urology.
[40] M. V. D. van den Brekel. Lymph node metastases: CT and MRI. , 2000, European journal of radiology.
[41] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[42] S. Herrell. Interventional robotic systems: Applications and technology state-of-the-art: Cleary K, Melzer A, Watson V, Kronreif G, Stoianovici D, Department of Radiology, Imaging Science and Information Systems Center, Georgetown University Medical Center, Washington, DC , 2007 .
[43] H Okamura,et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. , 2000, Radiology.
[44] J. Pouliot,et al. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. , 2004, International journal of radiation oncology, biology, physics.
[45] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[46] Thomas Wheeler,et al. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. , 2004, The Journal of urology.
[47] Peter Choyke,et al. Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.
[48] Riwa Kishimoto,et al. ADC value and diffusion tensor imaging of prostate cancer: Changes in carbon‐ion radiotherapy , 2008, Journal of magnetic resonance imaging : JMRI.
[49] M. Brekel. Lymph node metastases: CT and MRI. , 2000 .
[50] Ciprian Catana,et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.
[51] Usha Sinha,et al. In vivo diffusion tensor imaging of the human prostate , 2004, Magnetic resonance in medicine.
[52] J R Griffiths,et al. BOLD MRI of human tumor oxygenation during carbogen breathing , 2001, Journal of magnetic resonance imaging : JMRI.
[53] P. Carroll,et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.
[54] Jason A Koutcher,et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. , 2005, Radiology.
[55] L Verhey,et al. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.
[56] C. Claussen,et al. Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .
[57] M. Kattan,et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. , 2006, Radiology.
[58] John M Pauly,et al. Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience , 2007, Magnetic resonance in medicine.
[59] Katarzyna J Macura,et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.
[60] I. Kaplan,et al. Real time MRI-ultrasound image guided stereotactic prostate biopsy. , 2002, Magnetic resonance imaging.
[61] Nobuhiko Hata,et al. MR‐guided prostate interventions , 2008, Journal of magnetic resonance imaging : JMRI.
[62] D. Beyersdorff,et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. , 2005, Radiology.
[63] A. Neugut,et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. , 1999, Urology.
[64] Laura Curiel,et al. Control of prostate cancer by transrectal HIFU in 227 patients. , 2007, European urology.
[65] Mark Rijpkema,et al. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. , 2002, International journal of radiation oncology, biology, physics.
[66] B R Rosen,et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.
[67] Guglielmo Manenti,et al. Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer , 2007, Investigative radiology.
[68] Chris J. Diederich,et al. Magnetic Resonance-Guided High-Intensity Ultrasound Ablation of the Prostate , 2006, Topics in magnetic resonance imaging : TMRI.
[69] Leen Paelinck,et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[70] Anke M Hövels,et al. Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience. , 2006, Radiology.
[71] Pamela Catton,et al. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[72] M. Kattan,et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.
[73] Patrick W McLaughlin,et al. Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. , 2005, International journal of radiation oncology, biology, physics.
[74] J. Kurhanewicz,et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.
[75] M. Harisinghani,et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] A. Prando. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .
[77] P. Hoskin,et al. Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[78] A. Cesinaro,et al. 3-T MRI with phased-array coil in local staging of prostatic cancer. , 2008, Academic radiology.
[79] Junqian Xu,et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans , 2009, Magnetic resonance in medicine.
[80] Gary Luxton,et al. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. , 2004, International journal of radiation oncology, biology, physics.
[81] Harry J de Koning,et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.
[82] P. Hoskin,et al. The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[83] A R Padhani,et al. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. , 2001, Clinical radiology.
[84] P. Carroll,et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.
[85] J. Kurhanewicz,et al. Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score , 2007, European Radiology.
[86] G. Hanks,et al. Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer. , 1999, Urology.
[87] Guoying Liu,et al. Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. , 2005, Cancer research.
[88] G. De Meerleer,et al. Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. , 2007, European journal of radiology.
[89] D J Collins,et al. Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans , 2009, British Journal of Cancer.
[90] J Kurhanewicz,et al. Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.
[91] Dennis W J Klomp,et al. Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.
[92] A W Partin,et al. Disease progression following radical prostatectomy in men with Gleason score 7 tumor. , 1998, The Journal of urology.
[93] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[94] Rémi Souchon,et al. Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging. , 2007, European journal of radiology.
[95] J R Thornbury,et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.
[96] Clare Allen,et al. Dynamic contrast enhanced MRI in prostate cancer. , 2007, European journal of radiology.
[97] R. Franklin,et al. The Intermediary Metabolism of the Prostate: A Key to Understanding the Pathogenesis and Progression of Prostate Malignancy , 2000, Oncology.
[98] Bernd Hamm,et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.
[99] W. De Neve,et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. , 2004, International journal of radiation oncology, biology, physics.
[100] Silvia D. Chang,et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.
[101] Bong Hyun Chung,et al. Quantum dot‐based protein micro‐ and nanoarrays for detection of prostate cancer biomarkers , 2008, Proteomics.
[102] H. Hricak,et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. , 2006, Radiology.
[103] Thomas Hambrock,et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.
[104] C. Reddy,et al. Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen era , 2004, Cancer.
[105] K. Pummer,et al. Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the partin tables , 2009, Acta radiologica.
[106] D. Stoianovici,et al. Interventional robotic systems: Applications and technology state‐of‐the‐art , 2006, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.
[107] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[108] K. Stine,et al. Detection of free prostate specific antigen (fPSA) on a nanoporous gold platform. , 2008, The Analyst.
[109] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[110] Peter Gibbs,et al. Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.
[111] Tim Jones,et al. The role of PET scanning in radiotherapy , 2005 .
[112] O. Hélénon,et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. , 2002, Radiology.
[113] C. Kim,et al. Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.
[114] Evis Sala,et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.
[115] Jelle O. Barentsz,et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.
[116] D. Chia,et al. Direct electronic detection of prostate-specific antigen in serum. , 2007, Small.
[117] M. Kattan,et al. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. , 2000, The Journal of urology.
[118] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[119] S. Shariat,et al. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.
[120] B. Issa,et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[121] H M Pollack,et al. Magnetic resonance imaging of the prostate gland , 1990, Urologic radiology.
[122] M. Langer,et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. , 2005, European journal of radiology.
[123] Toyoaki Uchida,et al. Treatment of localized prostate cancer using high‐intensity focused ultrasound , 2006, BJU international.
[124] A. D'Amico,et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. , 1998, International journal of radiation oncology, biology, physics.
[125] Michael Scott,et al. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics , 2007, International journal of nanomedicine.
[126] J Kurhanewicz,et al. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. , 2001, Radiology.
[127] J Kurhanewicz,et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.
[128] M Dattoli,et al. A simple method to stabilize the prostate during transperineal prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.
[129] Gabor Fichtinger,et al. Robotic Assistant for Transperineal Prostate Interventions in 3T Closed MRI , 2007, MICCAI.
[130] Simon R Cherry,et al. Multimodality imaging: beyond PET/CT and SPECT/CT. , 2009, Seminars in nuclear medicine.
[131] A. Simmons,et al. Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study. , 2000, AJNR. American journal of neuroradiology.
[132] P. Carroll,et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.
[133] Jean-François Geschwind,et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. , 2004, AJR. American journal of roentgenology.
[134] J. Roy,et al. Prostate gland motion and deformation caused by needle placement during brachytherapy. , 2002, Brachytherapy.
[135] M. Kattan,et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.
[136] M. Kattan,et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. , 2003, Radiology.
[137] Michael W Kattan,et al. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. , 2004, Radiology.
[138] A. Partin,et al. Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients , 1999, Cancer.
[139] J. Kurhanewicz,et al. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[140] J Kurhanewicz,et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.